Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accriva Diagnostics was a commercial-stage in vitro diagnostics and medical device company focused on point-of-care blood testing for hospital and critical-care settings. The company emerged from the 2013 merger of International Technidyne Corporation and Accumetrics and built a portfolio spanning coagulation testing, platelet function analysis, CO-oximetry, and incision devices. Its best-known brands included Hemochron, VerifyNow, AVOXimeter, Tenderfoot, Tenderlett, and Surgicutt. Accriva distributed products to hospitals in more than 90 countries and maintained commercial and manufacturing operations in San Diego, California. In January 2017, Werfen and its subsidiary Instrumentation Laboratory acquired Accriva, after which the business became part of Instrumentation Laboratory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accriva Diagnostics Holdings.